113 related articles for article (PubMed ID: 7441662)
1. SAA amyloid protein levels in amyloid-prone chronic inflammatory disorders. Lack of association with amyloid disease.
Scheinberg MA; Benson MD
J Rheumatol; 1980; 7(5):724-6. PubMed ID: 7441662
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid protein SAA, C-reactive protein and lysozyme in leprosy.
Scheinberg MA; Masuda A; Benson MD; Mendes NF
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):133-7. PubMed ID: 572349
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
[TBL] [Abstract][Full Text] [Related]
4. Serum amyloid A in the assessment of early inflammatory arthritis.
Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
[TBL] [Abstract][Full Text] [Related]
5. Secondary amyloidosis and the serum amyloid precursor in leprosy: geographical variation and association with leukocytosis.
McAdam KP; Anders RF; Aiken G; Takitaki FF
Int J Lepr Other Mycobact Dis; 1977; 45(2):150-7. PubMed ID: 561759
[TBL] [Abstract][Full Text] [Related]
6. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).
Marhaug G; Sletten K; Husby G
Clin Exp Immunol; 1982 Nov; 50(2):382-9. PubMed ID: 7151331
[TBL] [Abstract][Full Text] [Related]
7. [Rapidly progressed secondary amyloidosis in a patient with Still's disease with gamma-allele in his SAA 1 gene].
Kaneko N; Mimori A; Baba S; Nara H; Shirota Y; Nagashima T; Hirata D; Yoshio T; Okazaki H; Kano S; Minota S
Ryumachi; 2000 Jun; 40(3):633-8. PubMed ID: 10920689
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis.
De Beer FC; Mallya RK; Fagan EA; Lanham JG; Hughes GR; Pepys MB
Lancet; 1982 Jul; 2(8292):231-4. PubMed ID: 6124669
[TBL] [Abstract][Full Text] [Related]
9. [A study of amyloidogenesis in relation to SAA levels in inflammatory diseases].
Tomita M; Isobe T; Matsumoto J; Fujita T
Ryumachi; 1985 Apr; 25(2):110-4. PubMed ID: 4035466
[No Abstract] [Full Text] [Related]
10. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
[TBL] [Abstract][Full Text] [Related]
11. Amyloidosis in rheumatoid arthritis.
Husby G
Ann Clin Res; 1975 Jun; 7(3):154-67. PubMed ID: 1103711
[TBL] [Abstract][Full Text] [Related]
12. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
[TBL] [Abstract][Full Text] [Related]
13. The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition.
Kisilevsky R; Benson MD; Axelrad MA; Boudreau L
Lab Invest; 1979 Sep; 41(3):206-10. PubMed ID: 470340
[TBL] [Abstract][Full Text] [Related]
14. Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1 beta and IL-6 to promote production of serum amyloid A by Hep3B cells.
McNiff PA; Stewart C; Sullivan J; Showell HJ; Gabel CA
Cytokine; 1995 Feb; 7(2):209-19. PubMed ID: 7780041
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
16. [Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis].
Okuda Y; Yamada T; Takasugi K; Takeda M; Nanba S; Onishi M; Miyamoto T; Inoue Y
Ryumachi; 1999 Feb; 39(1):3-10. PubMed ID: 10332210
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
Bokarewa M; Abrahamson M; Levshin N; Egesten A; Grubb A; Dahlberg L; Tarkowski A
J Rheumatol; 2007 Jun; 34(6):1293-301. PubMed ID: 17552057
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A protein and C-reactive protein in systemic amyloidosis.
Gertz MA; Skinner M; Sipe JD; Cohen AS; Kyle RA
Clin Exp Rheumatol; 1985; 3(4):317-20. PubMed ID: 4085162
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical outcome of renal amyloidosis.
Odabas AR; Cetinkaya R; Selcuk Y; Erman Z; Bilen H
Int J Clin Pract; 2002 Jun; 56(5):342-4. PubMed ID: 12137441
[TBL] [Abstract][Full Text] [Related]
20. [Secondary amyloidosis complicated rheumatoid arthritis, prevalence study in Italian population].
Benucci M; Maniscalchi F; Manfredi M
Recenti Prog Med; 2007 Jan; 98(1):16-9. PubMed ID: 17345875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
